DRS281787_1.png

Sigrima 420mg Injection

Therapeutic Class: ANTI NEOPLASTICS
Manufacturer:
Get Quote

Sigrima 420mg Injection is a monoclonal antibody designed to recognize and attach to specific proteins on the surface of cancer cells. Sigrima 420mg Injection gets attached to human epidermal growth factor receptor 2( HER2) and may kill or stop the growth of cancer cells. (N. Chimanlal Enterprises – Exporter of ONCO & Critical Care Products Mumbai INDIA)

Salt Composition: Pertuzumab (420mg)
Strength: Pertuzumab (420mg)
Pack Size: vial of 14 ml Injection
Uses: Breast cancer
Table Header
Salt Composition
Pertuzumab (420mg)
Strength
Pertuzumab (420mg)
Pack Size
vial of 14 ml Injection
Uses
Breast cancer
DISCLAIMER
N Chimanlal Enterprises (www.nicheformulations.com) is WHO GDP and ISO 9001 2015 Certified Pharmaceutical Wholesaler/ Supplier/ Exporters/ Importer from India. Product is supplied for Tenders/ Emergency imports/ Unlicensed, Specials, Orphan drug/ Name patient line/ RLD supplies/ Reference listed drugs/ Comparator Drug/ Bio-Similar/ Innovator samples For Clinical trials. Product names, logos, brands and other trademarks featured or referred to are the property of their respective Trademark Holders. The information provided here is for Informational purposes only.

Product information is meant for

WholesalersSuppliersExportersDoctorsMOH Tender SuppliesHospitalsBrandCROsComparator SuppliesGenericCooperate SourcingIndividual PatientsIndian Institutional Buyers
Recently Viewed
Categories

Select at least 2 products
to compare